Bibliography
- Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2(3):157-64
- Warburg O, Posener K, Negelein E. Über den stoffwechsel der tumoren. Biochem Z 1924;152:319-44
- Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: Progress and prospects. Mol Cancer 2013;12:152, 4598-12-152
- Lunt SY, Vander Heiden MG. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011;27:441-64
- Kim JW, Dang CV. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 2005;30(3):142-50
- Dubois RJ, Lin CC, Beisler JA. Synthesis and antitumor properties of some isoindolylalkylphosphonium salts. J Med Chem 1978;21(3):303-6
- Rideout DC, Calogeropoulou T, Jaworski JS, et al. Phosphonium salts exhibiting selective anti-carcinoma activity in vitro. Anticancer Drug Des 1989;4(4):265-80
- Manetta A, Gamboa G, Nasseri A, et al. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Gynecol Oncol 1996;60(2):203-12
- Modica-Napolitano JS, Aprille JR. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev 2001;49(1-2):63-70
- Li Z, Lopez M, Hardy M, et al. 99m)tc-labeled triphenylphosphonium derivative for the early detection of breast tumors. Cancer Biother Radiopharm 2009;24(5):579-87
- Millard M, Pathania D, Shabaik Y, et al. Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. PLoS One 2010;5:10
- Trnka J, Elkalaf M, Andel M. Lipophilic triphenylphosphonium cations inhibit mitochondrial electron transport chain and induce mitochondrial proton leak. PLoS One 2015;10(4):e0121837
- Millard M, Gallagher JD, Olenyuk BZ, Neamati N. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers. J Med Chem 2013;56(22):9170-9
- Theodossiou TA, Sideratou Z, Katsarou ME, Tsiourvas D. Mitochondrial delivery of doxorubicin by triphenylphosphonium-functionalized hyperbranched nanocarriers results in rapid and severe cytotoxicity. Pharm Res 2013;30(11):2832-42
- Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release 2012;159(3):393-402
- Porteous CM, Menon DK, Aigbirhio FI, et al. P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain. Biochim Biophys Acta 2013;1830(6):3458-65
- Han M, Vakili MR, Soleymani Abyaneh H, et al. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells. Mol Pharm 2014;11(8):2640-9
- Marrache S, Pathak RK, Dhar S. Detouring of cisplatin to access mitochondrial genome for overcoming resistance. Proc Natl Acad Sci USA 2014;111(29):10444-49
- Wallace DC. Mitochondria and cancer. Nat Rev Cancer 2012;12(10):685-98
- Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: What is so special about them? Trends Cell Biol 2008;18(4):165-73
- Pedersen PL. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 1978;22:190-274
- Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006;9(6):425-34
- Marino AA, Morris DM, Schwalke MA, et al. Electrical potential measurements in human breast cancer and benign lesions. Tumour Biol 1994;15(3):147-52
- Yang M, Brackenbury WJ. Membrane potential and cancer progression. Front Physiol 2013;4:185
- Wang J, Yang CT, Kim YS, et al. 64Cu-labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents. J Med Chem 2007;50(21):5057-69
- Pathak RK, Marrache S, Harn DA, Dhar S. Mito-DCA: A mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate. ACS Chem Biol 2014;9(5):1178-87
- Marrache S, Dhar S. The energy blocker inside the power house: Mitochondria targeted delivery of 3-bromopyruvate. Chem Sci 2015;6(3):1832-45